SIALIX

SIALIX is an innovative, phytocannabinoid-based dietary supplement specifically designed to support eye health in patients with glaucoma. Patent pending.
Glaucoma is a neurodegenerative disease characterized by progressive damage to retinal ganglion cells and the optic nerve, potentially leading to irreversible vision loss. Although increased intraocular pressure (IOP) is not a direct etiopathogenetic cause, it represents the main risk factor and a key driver of disease progression.
In addition to ocular hypertension, oxidative stress, microvascular dysfunction, and impairment of neuroprotective mechanisms play a significant role in retinal damage associated with glaucoma.